Key Highlights
● Revenue fell and the adjusted net loss persisted
● Non-cash Warrant gain lifted GAAP profit
● DOE does not currently intend to exercise further HALEU options
● Piketon centrifuge Manufacturing is ahead of schedule
Centrus Energy Corp. (NYSE:LEU), among the more closely followed nuclear-linked energy stocks, reported third-quarter results that looked strong or weak depending on which line a reader chose. Net Income under generally accepted accounting principles climbed well above the prior-year figure, yet Revenue fell, gross results worsened and the company swung to a net loss on the adjusted basis it publishes alongside its statutory numbers.
The gap between those measures traces largely to a non-cash item. Centrus recorded a sizeable gain from a change in the Fair Value of its warrant liability, a line that did not exist in the same quarter a year earlier. Once that gain and other adjustments were removed, the Bethesda, Maryland, company's quarter showed an operating Business absorbing rising expansion costs while waiting for its largest project to begin producing.
The release also carried a disclosure with longer-lasting implications. The Department of Energy has told Centrus that it does not currently intend to exercise further production Options under the HALEU Operation Contract, the agreement that has anchored the company's Technical Solutions segment. The department's proposed budget for the coming fiscal year also includes no further funding to operate the cascade under that contract.
Those developments arrive as the company reports progress on the physical build-out of its enrichment business. Centrus said it completed manufacturing and began shipping the first centrifuge from its Oak Ridge, Tennessee, plant ahead of its year-end target, a milestone Chief Executive Officer Amir Vexler placed months ahead of schedule.
How the Warrant Line Changed the Headline
Warrants classified as liabilities are remeasured each reporting period, and changes in their value flow through earnings. In the company's quarterly report, Centrus recorded a warrant Liability at the end of September where none had existed at the close of the previous year. The change in value during the quarter produced a gain large enough to outweigh the operating loss and lift pre-tax income into positive territory.
Investment income also helped, rising from the prior-year period while the company held a large cash balance. An income tax benefit added to the result, although that benefit was smaller than the one recorded a year earlier.
The adjusted figures remove the warrant gain and related items and also account for short-term expansion costs that cannot be capitalized, along with stock-based compensation. On that basis, Centrus reported a net loss compared with adjusted net income in the prior-year quarter. Per-share results followed the same pattern, with positive GAAP Earnings and a negative adjusted figure.
Neither measure is complete on its own. The GAAP profit reflects real accounting requirements but says little about the cash Economics of enrichment or uranium sales. The adjusted measure strips out several items but relies on company-defined exclusions. Read together, the figures suggest that the core quarter was weak while the Balance Sheet remained unusually large for a company of this type.
Lumpy Deliveries Weigh on the Fuel Segment
Revenue in the LEU segment, which covers separative work units and uranium, declined from the prior-year period. The largest Factor was uranium, where sales fell mainly because of lower volume. Separative work unit revenue moved in the opposite direction, rising on both higher Volume and a higher average price.
That improvement in pricing did not translate neatly into profit. The unit cost of separative work rose faster than the average selling price, and the segment finished with a gross loss, though that loss was slightly narrower than the one a year earlier. Management attributed the outcome to the mix of contracts in the period.
Centrus has repeatedly noted that this business does not move smoothly. Its contracts typically span multiple years and carry annual purchase commitments, so deliveries can concentrate in particular quarters. Year-to-date figures show how much difference that timing can make: total revenue for the year to date edged above the same period of the previous year even though the latest quarter fell, as stronger uranium sales offset a decline in separative work revenue.
Full-year guidance implies more variability ahead. Centrus expects consolidated revenue within a range that sits well above the amount reported through September, which would require a fourth quarter substantially larger than the one just completed. The outlook assumes no significant change in restrictions on Russian low-enriched uranium or other uranium imports and sales, no major economic downturn and successful execution of expansion projects.
Why the Department of Energy Disclosure Matters
The Technical Solutions segment also shrank from a year earlier, and the HALEU Operation Contract accounted for much of the revenue decline. With costs slightly higher, the segment moved from a Gross Profit to a gross loss. In its quarterly filing, the company traces the recent history of that contract in some detail.
Production under one option finished in the middle of June. A following option covered a period with no HALEU production and ended on the last day of September. The filing then states: "DOE has communicated that it does not currently intend to exercise further production options." Centrus added that it has no obligation to work beyond the department's funding and could face material additional costs if further commitments are not made.
The contract represents a meaningful part of reported backlog. Technical Solutions Backlog includes funded, unfunded and unexercised-option amounts, and the release ties the HALEU Operation Contract to the segment's total. A portion of the headline backlog therefore depends on options the customer has said it does not presently plan to use.
The shift was not wholly unexpected. In a July announcement, Centrus said it had finalized a competitively awarded task order from the department to support commercial-scale HALEU production capacity at Piketon, Ohio, and intended to operate the existing cascade privately to serve near-term customer needs. The latest quarterly release says the company is now enriching HALEU for the commercial market using that existing cascade. In effect, the federal relationship is moving from paying for operation of a demonstration cascade toward funding new capacity.
The Backlog Beneath the Headline Figure
Centrus reported total backlog extending for well over a decade, and most of it sits in the LEU segment. The composition of that amount deserves as much attention as its size. A large majority of the LEU segment figure consists of contingent LEU and HALEU sales commitments, most of which are under definitive agreements.
Those contingent commitments are tied to operational milestones supporting potential construction of production capacity at Piketon. Their conversion into revenue therefore depends on the same expansion program that is driving spending today. For now, the backlog is more usefully read as a measure of customer interest and contractual positioning, with timing that is closely linked to construction and financing.
Supply arrangements add another layer of complexity. The company's filing refers to federal legislation banning imports of Russian low-enriched uranium, subject to Department of Energy waivers, as well as Russian decrees restricting exports by the supplier TENEX. Centrus has a Supply contract with TENEX that continues for several more years, and the company lists the conflict in Ukraine, sanctions and trade restrictions among its principal risks.
Spending Accelerates at Oak Ridge and Piketon
The expansion is visible throughout the financial statements. Capital Expenditure for the year through September rose dramatically from a small base, and net property, plant and equipment multiplied from the year-end level. Inventories fell over the same period, while amounts owed for equipment and construction purchases increased sharply.
Centrus reported several milestones ahead of its own targets. Beyond the first centrifuge shipment, it said it finalized contracts with all suppliers deemed critical to the supply chain and completed its first certified-for-construction package. It also completed its Acquisition of Westerman, which Vexler described as a move that both reduces risk and diversifies the business.
Market data, published by the American Nuclear Society, reported on an event held at Oak Ridge to mark the shipment. Vexler said it "connects American manufacturing in Tennessee and American uranium enrichment in Ohio." The publication reported that the Tennessee site is the only US plant building gas centrifuges for commercial enrichment, and that new cascades built with US-made parts are expected to come online before the decade ends.
The company's July announcement gave a similar timetable for first new capacity. It also described planned construction and operating jobs in Ohio and manufacturing jobs in Tennessee as company projections. In the latest guidance, Centrus raised its Piketon hiring goal for the year while keeping a separate net hiring goal for Oak Ridge, and it gave a broad range for full-year capital deployment driven by the centrifuge manufacturing build-out.
A Large Cash Pile With Heavy Demands on It
Liquidity remains a defining feature of the story. Cash and cash equivalents rose from the end of last year, helped by proceeds from common stock, pre-funded warrants and common warrants. The increase came even though Operating Activities used cash during the year through September, compared with a substantial inflow in the same period last year.
Long-term Debt remains significant, with convertible notes among the obligations named in the company's risk disclosures, and interest expense increased from the prior-year quarter. Investment income on the cash balance currently exceeds that interest cost, an arrangement that supports reported earnings while expansion spending ramps up.
The forward-looking statements point to a shelf registration filed recently, a routine mechanism that gives companies flexibility to offer securities but does not by itself indicate an offering. The release also names the ability to raise capital for expansion among its risks, a reminder that management does not treat the current balance as the end of the funding question.
The Lease Question at the Center of the Plan
The most specific near-term uncertainty concerns the ground on which the project sits. The company's lease on the Piketon site runs only until the autumn of next year. An amendment signed in October expressly permits continued use of the demonstration cascade, and a separate transfer agreement moved title to certain materials and responsibility for Facility costs to a Centrus subsidiary.
The department has said it will work toward a long-term extension before the end of this year. The filing, however, says the department "is under no obligation to do so." The release warns that a failure to secure acceptable terms could force the company to delay, scale back or abandon the expansion and could trigger a significant non-cash charge on capitalized improvements at the site.
That language is standard in form but unusually concrete in substance because so much capital is now being committed to a leased federal site. The outcome of those discussions is likely to be one of the clearer signals available to Market Participants in the weeks ahead.
A Competitive and Policy Landscape in Motion
Centrus is not building in a vacuum. According to market data, BWX Technologies began manufacturing centrifuges this year at its own Oak Ridge development facility with a focus on unobligated uranium, although it does not plan to enrich for the commercial market. Urenco USA's plant in New Mexico remains the only commercial enrichment facility currently operating in the country, and it does not produce unobligated material because of its ownership.
The term "unobligated" matters because national security uses require uranium produced entirely with US equipment and material. Vexler has argued that an unobligated supply chain allows Centrus to serve both defense and commercial customers. The same trade publication, however, cited a government watchdog report from August indicating that existing unobligated supply for nuclear security purposes is expected to last for well over a decade, and that unobligated HALEU is not currently needed for those missions, though it could be later.
Those details suggest that the commercial side of the plan may carry considerable weight. Demand from the existing reactor fleet for low-enriched uranium and from next-generation reactor developers for HALEU would help determine how much of the contingent backlog becomes firm over time, while foreign producers remain a named competitive risk.
Markers for the Months Ahead
Several items now stand out in the company's disclosures. The first is the fate of the Piketon lease extension and whether it arrives within the department's stated timeframe. The second is whether Centrus can sustain commercial HALEU operations on the existing cascade after the end of federal production funding, and at what margins.
A third concerns the timing of deliveries needed to reach the full-year revenue range, given the weight now placed on the final quarter. A fourth is the pace at which capital deployment rises and whether it remains within the guided range as more centrifuges and construction packages move forward. Integration of Westerman, reliance on third-party suppliers and any change to rules governing Russian material also remain on the list of disclosed risks.
For now, the quarter leaves a mixed record: a headline profit shaped by accounting, an operating loss shaped by investment, and a manufacturing timetable running ahead of plan while the federal contract that supported the existing cascade winds down. How those strands resolve will depend largely on execution at Oak Ridge and Piketon and on decisions that remain, in part, in Washington.

_11_13_2026_19_06_43_490830.jpg)




Please wait processing your request...